Jodas Expoim Profile
Key Indicators
- Authorised Capital ₹ 115.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 113.16 Cr
as on 23-10-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 125.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 91.75 Cr
as on 23-10-2024
About Jodas Expoim
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 115.50 Cr and a paid-up capital of Rs 113.16 Cr.
The company currently has active open charges totaling ₹125.00 Cr. The company has closed loans amounting to ₹91.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jodas Expoim Private Limited India is Hirak Raj as COMPANY SECRETARY. Shashi Singh, Satyendra Singh, Piyush Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U21001TG2006PTC110218
- Company No.
110218
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Jodas Expoim Private Limited offer?
Jodas Expoim Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Clarithromycin Injection, Antibiotic Injection, Meropenem Injection, Piperacillin Tazobactam Injection.
Who are the key members and board of directors at Jodas Expoim?
Executive Team (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shashi Singh | Managing Director | 08-Jan-2008 | Current |
Satyendra Singh | Managing Director | 08-May-2012 | Current |
Hirak Raj | Company Secretary | 10-Oct-2022 | Current |
Jyoti Loomba | Managing Director | 04-Sep-2006 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Piyush Gupta | Director | 11-Jan-2012 | Current |
Financial Performance and Corporate Structure Insights of Jodas Expoim.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Jodas Expoim?
Unlock access to Jodas Expoim's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Jodas Consumer Care Private LimitedActive 7 years 1 month
Shashi Singh, Satyendra Singh and 1 more are mutual person
- Novalek Pharmaceutical Private LimitedActive 18 years 11 months
Shashi Singh and Jyoti Loomba are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 30 Aug 2024 | ₹50.00 Cr | Open |
Others Creation Date: 07 Nov 2023 | ₹75.00 Cr | Open |
Hdfc Bank Limited Creation Date: 31 May 2019 | ₹39.00 Cr | Satisfied |
How Many Employees Work at Jodas Expoim?
Unlock and access historical data on people associated with Jodas Expoim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jodas Expoim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jodas Expoim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.